<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39348452</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2398-9238</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Endocrinology, diabetes &amp; metabolism</Title><ISOAbbreviation>Endocrinol Diabetes Metab</ISOAbbreviation></Journal><ArticleTitle>Women Suffered More Than Men Both During and After the COVID-19 Pandemic-A Cross-Sectional Study Among 29,079 Patients With Type 2 Diabetes.</ArticleTitle><Pagination><StartPage>e70004</StartPage><MedlinePgn>e70004</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70004</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/edm2.70004</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the gender differences and the disparities between infected and noninfected patients with type 2 diabetes (T2D) regarding patient-reported experiences during the COVID-19 pandemic in Norway.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Register study using questionnaires sent electronically to patients with T2D, June 2022. The questionnaire included 82 questions covering COVID-19 disease, symptoms, medications, comorbidities, hospital care, possibility of working from home and information received from health authorities. Clinical and demographic data were collected from the Norwegian diabetes registry for adults.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 29,079 T2D patients participated, of whom 38.1% were women. Patients infected with COVID-19 were younger, had shorter diabetes duration and less comorbidities than noninfected (p&#x2009;&lt;&#x2009;0.01). Women reported significantly more anxiety, depression and fear of not getting their diabetes medication than men did. Most patients were vaccinated against COVID-19 (98.3%), whereas approximately 60% had received seasonal flu vaccine, and only 27.2% the pneumococcal vaccine. Women described more vaccine adverse effects and long Covid symptoms. Overall, 14% experienced vaccine complications and 27.3% of infected individuals reported long Covid symptoms. 2.4% of the infected patients needed hospital admission. Patients were satisfied with the follow-up of their diabetes, and with information from the government during the pandemic.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Female patients were more likely to experience a prolonged Covid course, and higher degree of adverse effects from the COVID-19 vaccine than male patients. Also, long Covid symptoms were significantly more often reported among female patients, while men were more prone to be hospitalised when infected. Hospitalised patients, both men and women, had significantly higher HbA1C than those who were not hospitalised. T2D patients had a surprisingly low pneumococcal vaccination coverage, despite recommendations in national guidelines.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Endocrinology, Diabetes &amp; Metabolism published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ueland</LastName><ForeName>Grethe &#xc5;str&#xf8;m</ForeName><Initials>G&#xc5;</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernes</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Tone Vonheim</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandberg</LastName><ForeName>Sverre</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc5;svold</LastName><ForeName>Bj&#xf8;rn Olav</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology, Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf8;vaas</LastName><ForeName>Karianne Fjeld</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>John Graham</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Endocrinol Diabetes Metab</MedlineTA><NlmUniqueID>101732442</NlmUniqueID><ISSNLinking>2398-9238</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39348452</ArticleId><ArticleId IdType="pmc">PMC11441567</ArticleId><ArticleId IdType="doi">10.1002/edm2.70004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berbudi A., Rahmadika N., Tjahjadi A. I., and Ruslami R., &#x201c;Type 2 Diabetes and Its Impact on the Immune System,&#x201d; Current Diabetes Reviews 16, no. 5 (2020): 442&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7475801</ArticleId><ArticleId IdType="pubmed">31657690</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurnaghan S. J., Weir A., Bishop J., et&#xa0;al., &#x201c;Risks of and Risk Factors for COVID&#x2010;19 Disease in People With Diabetes: A Cohort Study of the Total Population of Scotland,&#x201d; Lancet Diabetes and Endocrinology 9, no. 2 (2021): 82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832778</ArticleId><ArticleId IdType="pubmed">33357491</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron E., Bakhai C., Kar P., et&#xa0;al., &#x201c;Associations of Type 1 and Type 2 Diabetes With COVID&#x2010;19&#x2010;Related Mortality in England: A Whole&#x2010;Population Study,&#x201d; Lancet Diabetes and Endocrinology 8, no. 10 (2020): 813&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426088</ArticleId><ArticleId IdType="pubmed">32798472</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman N., Knighton P., Kar P., et&#xa0;al., &#x201c;Risk Factors for COVID&#x2010;19&#x2010;Related Mortality in People With Type 1 and Type 2 Diabetes in England: A Population&#x2010;Based Cohort Study,&#x201d; Lancet Diabetes and Endocrinology 8, no. 10 (2020): 823&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426091</ArticleId><ArticleId IdType="pubmed">32798471</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariou B., Hadjadj S., Wargny M., et&#xa0;al., &#x201c;Phenotypic Characteristics and Prognosis of Inpatients With COVID&#x2010;19 and Diabetes: The CORONADO Study,&#x201d; Diabetologia 63, no. 8 (2020): 1500&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256180</ArticleId><ArticleId IdType="pubmed">32472191</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi Q. H., Ashraf T., Rehman K., Khosa M. K., and Akash M. S. H., &#x201c;Therapeutic Interventions of Remdesivir in Diabetic and Nondiabetic COVID&#x2010;19 Patients: A Prospective Observational Study Conducted on Pakistani Population,&#x201d; Journal of Medical Virology 93, no. 12 (2021): 6732&#x2013;6736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426731</ArticleId><ArticleId IdType="pubmed">34351640</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Norwegian Directorate of Health&#x2010;Hig Risk Groups: The Norwegian Directorate of Health
, 2021, https://www.helsenorge.no/en/coronavirus/high&#x2010;risk&#x2010;groups/.</Citation></Reference><Reference><Citation>
Cummings M. J., Baldwin M. R., Abrams D., et&#xa0;al., &#x201c;Epidemiology, Clinical Course, and Outcomes of Critically Ill Adults With COVID&#x2010;19 in New York City: A Prospective Cohort Study,&#x201d; medRxiv, 2020, https://pubmed.ncbi.nlm.nih.gov/32442528/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>
Folkehelseinstituttet
, &#x201c;Vaksineanbefalinger Influensasesongen 2022&#x2013;2023: Folkehelseinstituttet,&#x201d; 2022, https://www.fhi.no/va/influensavaksine/influensavaksine/.</Citation></Reference><Reference><Citation>Kautzky&#x2010;Willer A., Harreiter J., and Pacini G., &#x201c;Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus,&#x201d; Endocrine Reviews 37, no. 3 (2016): 278&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890267</ArticleId><ArticleId IdType="pubmed">27159875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J., &#x201c;Long COVID or Post&#x2010;COVID&#x2010;19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments,&#x201d; Infectious diseases (London) 53, no. 10 (2021): 737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojanic I., Sund E. R., Sletvold H., and Bjerkeset O., &#x201c;Prevalence Trends of Depression and Anxiety Symptoms in Adults With Cardiovascular Diseases and Diabetes 1995&#x2013;2019: The HUNT Studies, Norway,&#x201d; BMC Psychology 9, no. 1 (2021): 130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406588</ArticleId><ArticleId IdType="pubmed">34465377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueland G. A., Ernes T., Vonheim Madsen T., et&#xa0;al., &#x201c;Fear of Covid 19 During the Third Wave of Infection in Norwegian Patients With Type 1 Diabetes,&#x201d; PLoS One 17, no. 7 (2022): e0272133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9333287</ArticleId><ArticleId IdType="pubmed">35901064</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K. G., Brokstad K. A., et&#xa0;al., &#x201c;Long COVID in a Prospective Cohort of Home&#x2010;Isolated Patients,&#x201d; Nature Medicine 27, no. 9 (2021): 1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarroel M. A. and Vahratian A., &#x201c;Vaccination Coverage Among Adults With Diagnosed Diabetes: United States, 2015,&#x201d; NCHS Data Brief 265 (2016): 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27930282</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi A., Alamer E., Daws D., et&#xa0;al., &#x201c;Evaluation of Side Effects Associated With COVID&#x2010;19 Vaccines in Saudi Arabia,&#x201d; Vaccines (Basel) 9, no. 6 (2021): 674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8235009</ArticleId><ArticleId IdType="pubmed">34207394</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster S., Esposito D., Aranda&#x2010;Guillen M., et&#xa0;al., &#x201c;Self&#x2010;Management and Hospitalization in 615 Swedish Patients With Addison's Disease During the Coronavirus Disease 2019 Pandemic: A Retrospective Study,&#x201d; European Journal of Endocrinology 188, no. 2 (2023): 189&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">36721983</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawshani A., Kjolhede E. A., Rawshani A., et&#xa0;al., &#x201c;Severe COVID&#x2010;19 in People With Type 1 and Type 2 Diabetes in Sweden: A Nationwide Retrospective Cohort Study,&#x201d; Lancet Regional Health &#x2013; Europe 4 (2021): 100105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086507</ArticleId><ArticleId IdType="pubmed">33969336</ArticleId></ArticleIdList></Reference><Reference><Citation>Telle K. E., Grosland M., Helgeland J., and Haberg S. E., &#x201c;Factors Associated With Hospitalization, Invasive Mechanical Ventilation Treatment and Death Among All Confirmed COVID&#x2010;19 Cases in Norway: Prospective Cohort Study,&#x201d; Scandinavian Journal of Public Health 49, no. 1 (2021): 41&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">33461404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. W. S., Lee S., Dong M. C., and Taniguchi M., &#x201c;What Factors Drive the Satisfaction of Citizens With governments' Responses to COVID&#x2010;19?,&#x201d; International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 102 (2021): 327&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">33115678</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew M. S., Kattainen S., Haase N., et&#xa0;al., &#x201c;A Descriptive Study of the Surge Response and Outcomes of ICU Patients With COVID&#x2010;19 During First Wave in Nordic Countries,&#x201d; Acta Anaesthesiologica Scandinavica 66, no. 1 (2022): 56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652908</ArticleId><ArticleId IdType="pubmed">34570897</ArticleId></ArticleIdList></Reference><Reference><Citation>
Folkehelseinstituttet
, &#x201c;Ukerapporter Om Covid&#x2010;19, Influensa Og Andre Luftveisinfeksjoner: Folkehelseinstituttet; 2020/2021/20222023,&#x201d;
https://www.fhi.no/publ/2020/koronavirus&#x2010;ukerapporter/.</Citation></Reference><Reference><Citation>Ek S., &#x201c;Gender Differences in Health Information Behaviour: A Finnish Population&#x2010;Based Survey,&#x201d; Health Promotion International 30, no. 3 (2015): 736&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">23985248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>